News

The Society for Clinical Research Sites (SCRS) and the National Association of Veterans’ Research and Education Foundations (NAVREF) have announced a partnership.

Thermo Fisher Scientific has announced the opening of its new GMP standard facility in South Korea.

MediData announced that Techfields Pharma has selected its Clinical Cloud solution to power a Phase II schemic stroke study.

Veeva Systems has unveiled the results of its 2016 Paperless TMF Survey: CRO Report.

The Society for Clinical Research Sites (SCRS) has announced Bioclinica as its newest Global Impact Partner.

One year ago, the China Food and Drug Administration (CDFA) was pushed to accelerate its activities to promote new or updated regulations and guidelines. Since then the results have been smoother processes for innovative drug development in China.

iCardiac Technologies and SNBL Clinical Pharmacology Center have announced a collaboration on cardiac safety studies in Japan.

The Society for Clinical Research Sites (SCRS) has chosen Acurian as their corporate sponsor for its SCRS Ambassador Program in Poland.

The Pharmaceutical Benchmarking Forum has released data concerning R&D success rates of large and small molecules.

ERT has updated its Insights Cloud trial oversight solution to enable sponsors and CROs to collaborate by sharing electronic monitoring visit reports and issue management, tracking, and reporting.

Patients of gastroesophageal reflux disease (GERD) that have been frequently diagnosed, or misdiagnosed, have been dissatisfied with the available treatment. To resolve this issue, industry players must define meaningful endpoints for future trials, incorporate patient reported outcomes, and apply biomarkers.

TransCelerates work on their clinical trial Quality Management Systems (QMS) initiative began about one year ago. This article summarizes findings from a recent DIA publication about the initiative and evaluates potential issues during QMS framework implementation.

Medidata and SHYFT Analytics have partnered with a goal of increasing access to healthcare data analytics in clinical trials.

Following the UK’s decision to leave the European Union, the result has been uncertainty and speculation as pharma attempts to understand its implications. How this change will effect the pharma and life sciences industry as well as the European community remains to be seen.

Cancer therapy has seen progress - not groundbreaking, but improving thanks to the scientific and technological tools at our disposal. This fall offers industry events and trial evaluations that aim to continue this progressive trend toward a breakthrough.

Cenduit announced the launch of new drug management modules for its interactive response technology (IRT) system.

The director general leaves his position at the European Federation of Pharmaceutical Industries and Associations (EFPIA) after five years to pursue “a fresh challenge.”

Just because information can be gathered and shared more quickly among stakeholders does not mean that it can identify risk. This article describes the need for pharma to adopt fully-vetted, standardized operational-level time, cost and quality performance metrics as tools for tracking and predicting performance.

Japanese CRO CMIC HOLDINGS has chosen goBalto’s Activate solution to further its clinical study startup process throughout Asia.